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Background: We describe our 8-year experience with the use of endovascular techniques (ET) for the treatment of
abdominal aortic aneurysms (AAA) through a straight endograft.
Methods: We retrospectively reviewed data of all patients who were treated for AAA using ET in two centres from
1998 to 2012 and who received a single straight endograft (group A) or a double straight tube (group B).
Outcomes were analyzed to assess survival, absence of endoleak and absence of reintervention for both groups.
Log-rank and Chi-Square were used as appropriate to make comparison between the two groups. P values < .05
were considered statistically significant.
Results: Fifty-three patients from 1998 to May 2012 were treated for AAA using a straight endograft. In 28 cases
(52.8%) a single aortic straight tube was used (Group A), while in the remaining cases a “double trombone
technique” was used (Group B).
Primary success was obtained in 52 cases (98.1%). In one patient of group A immediately after the operation we
observed a type Ia endoleak, which was correct with a proximal aortic cuff.
Fluoroscopy time, operation time, amount of intraprocedural contrast medium and blood loss were slightly higher
for group B, even if not significantly. Mortality at 30 days was nil for both groups. Mean follow-up was 49 months
(range 2–153 months).
Five patients died in group A, four of them for a neoplastic disease and the remaining for aortic rupture. No
patients died in group B. Endoleaks occurred more frequently in patients of group A (5 type I endoleaks and 1 type
II endoleak from a lumbar artery).
Reintervention were more frequent for patients of group A, being type I endoleak the main cause. A stent fracture
was observed in a patient who received EVAR by “trombone technique” 3 months later. Reintervention was then
necessary and a third stent was successfully placed to cover the lesion.
Conclusions: In our experience the endovascular repair of AAA using straight aortic endografts was a safe and
effective technique. Reintervention and endoleaks were slightly more frequent in patients who had received a
single endograft compared to patients who were treated using the “trombone technique”.
Keywords: EVAR, Straight endograft, AAA* Correspondence: danymazzak83@libero.it
1First Unit of Vascular Surgery, IRCCS Policlinico San Donato, University of
Milan, piazza E. Malan 1, San Donato Milanese, Milan 20097, Italy
Full list of author information is available at the end of the article
© 2013 Mazzaccaro et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Mazzaccaro et al. Journal of Cardiothoracic Surgery 2013, 8:114 Page 2 of 6
http://www.cardiothoracicsurgery.org/content/8/1/114Background
Historically, the first endovascular repair of an abdominal
aortic aneurysms (EVAR) in the western world was
performed in 1990 by Dr. Parodi [1], who put a straight
endograft into the abdominal aorta. Limitations of the use
of a similar device soon became evident besides its clear
advantages, as the straight tube lacked of both columnar
support and distal sealing to ensure enough durability over
time, causing migration and subsequent type I endoleak.
To overcome this problem, a second balloon-expandable
stent was introduced to give more support and distal
sealing to the first tube [2].
However the marketing of new self-expandable mate-
rials and bifurcated endoprosthesis, which had moreover
a smaller caliber than the previous ones, caused a halt to
the spread of straight stents and balloon-expandable
materials.
Indeed, these second generation grafts were not a
panacea, as they showed a reduced reliability over time
as well, resulting in high number of reintervention after
EVAR in the medium and long term [3]. These are fac-
tors to be strongly considered during the decision to
perform EVAR, as reinterventions represent adjunctive
expenses for society.
In 2007, Ruppert et al. [4] reported their experience
about a modified technique for deploying tubular straight
grafts (“Trombone technique”), with results which com-
pared favourably to those obtained using bifurcated grafts
in terms of durability and freedom from endoleaks in the
early and mid-term.
As in our institution straight aortic endografts are still
used in well selected patients, we decided to critically re-
view our 14-year experience in endovascular treatment of
aortic aneurysms through the use of tubular endoprosthesis
with both conventional and trombone technique.
Methods
The research described in this manuscript was approved
by the ethics committee at each respective institution
and was conducted per the guidance set forth in the
Declaration of Helsinki. Informed consent was obtained
from each patient.
We retrospectively reviewed data of all patients who
were treated for abdominal aortic aneurysm (AAA)
using endovascular technique (ET) in our two centres
from 1998 to May 2012 and who received a single tubu-
lar aorto-aortic endograft (group A) or a double straight
tube (group B).
Single or double straight endograft were used in case of
AAA which did not involve aortic bifurcation, with a good
proximal neck (>15 mm long, presence of calcification or
thrombus in less than 50% of vessel perimeter, <30 mm
wide and with an angulation <60°) and a good distal neck
(>20 mm long, with an angulation <55° and presence ofcalcification or thrombus <30 mm). Challenging ana-
tomies were excluded.
The single straight tube (Endologix®, Talent®, Vanguard®,
Parodi® or Baxter Lifepath®) was placed according to the
specific instructions for the device and to preoperative
imaging data (Figure 1).
In group B, the two aortic tubes were placed using the
“Trombone-technique” (TT, Figure 2): a first Endologix®
aortic cuff is laid on the aortic carrefour. A second
Endologix® aortic cuff with a proximal free-flow to en-
hance proximal fixation is deployed cranially to the first,
next to the origin of the renal arteries. This second cuff,
which has a slightly larger caliber, is imbricated with the
previous one with 2.5-3 cm of overlap. A 20% oversizing is
calculated for proximal and distal devices, while the length
of the grafts is chosen so that the sum of their extent ex-
ceeds about 3 cm the distance between the origin of the
distal renal artery and the aortic carrefour. The purpose of
this technique is to ensure stability to the graft-system,
which is integral with the aortic bifurcation.
All procedures were performed in the operating room
using a mobile C arm. Endografts were deployed using
mainly a surgical exposure of femoral vessels.
Long term follow-up was obtained from outpatient
visits and computed tomography (CT) scan or duplex
scans. Imaging was performed every three months du-
ring the first year after operation and therefore annually.
All patients who survived were also interviewed through
telephone calls before statistical analysis, which was per-
formed using the software JMP® 5.1.2 (SAS Institute Inc.).
Outcomes were analyzed to evaluate survival, presence
of endoleak and reintervention for both groups. Primary
success was defined as the absence of any type of pe-
rioperative endoleak.
Log-rank and Chi-Square tests were used as appro-
priate to make comparison between the two groups.
P values < .05 were considered statistically significant.Results
Fifty-three patients from 1998 to May 2012 were treated
for AAA using a straight endograft. Of them, 47 were men
(88.6%). Patient’s mean age was 72.5 years (range 58–84).
Four patients had a neoplastic disease, as shown in
Table 1.
Forty AAA had atherosclerotic and degenerative
aetiology, one of them was treated in an emergency set-
ting due to fissuration. There were 4 penetrating ab-
dominal aortic ulcers (one of them required emergent
operation for hemodynamic instability in an obese man)
and two intramural hematomas. The remaining were aor-
tic pseudoaneurysms of proximal anastomosis in AAA
which had previously been treated using open surgical re-
pair (OSR).
Figure 1 Placement of a single tube which completely excluded the AAA.
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besides Vanguard® grafts (7 cases), Talent®, Parodi® and
Baxter Lifepath® (2 cases each). In 28 cases (52.8%) a
single aortic straight tube was used (Group A), while in
the remaining cases a “double trombone technique” was
used, as described previously (Group B).
Primary success was obtained in 52 cases (98.1%). In one
patient of group A we observed a type Ia endoleak at the
end of the procedure, which was immediately corrected: an
aortic cuff was then placed proximally and the patient was
discharged in 4th post-operative day (POD).
Two patients of group A and two of group B respect-
ively needed additional procedures during the operation.
In particular, in both patients who received a single aor-
tic tube, a short independent covered stent (Viabahn®)
was placed to correct a left common iliac aneurysm. In
group B, one patient underwent a right renal translumi-
nal angioplasty for a severe stenosis, and a last patientFigure 2 Trombone technique and complete exclusion of the AAA.needed a right common femoral endarterectomy pre-
vious to the aortic endografting.
Intraprocedural and in-hospital data are described in
Table 2 for both groups. Fluoroscopy time, operation
time, amount of intraprocedural contrast medium and
blood loss were slightly higher for group B, even if not
significantly. On the other side, in-hospital stay was
similar for both groups. Neither blood transfusion nor
intensive care unit was necessary in any case.
Mortality at 30 days was nil for both groups. A post-
implantation syndrome occurred in 6 patients (4 of them
had received a single aortic tube) during hospital stay
and immediately resolved after administration of low-
dose corticosteroids. We didn’t observe any other com-
plication within 30-days (Table 3).
Mean follow-up was 49 months (range 2–153 months).
Five patients died in group A, four of them for a neo-
plastic disease which was already present at the moment
Table 1 Patients’ characteristics and anatomical data of
both groups
Single tube
(n = 28)
Trombone
Technique (n = 25)
P
Male Sex 25 (89.3%) 22 (88%) .13
Mean age, years (Range) 71.2 (67–84) 73.4 (58–82) .42
Aetiology
Atherosclerosis/Degeneration 21 (75%) 19 (76%) .48
IMH 1 (3.6%) 1 (4%) .16
PAU 3 (10.7%) 1 (4%) .06
PSA 3 (10.7%) 4 (16%) .07
Comorbidities
Diabetes 13 (46.4%) 6 (24%) .32
Coronary Artery Disease 9 (32.1%) 7 (28%) .19
Previous stroke/TIA 0 (0%) 1 (4%) .21
Hypertension 18 (64.3%) 10 (40%) .12
Hypercholesterolemia 6 (21.4%) 4 (16%) .45
Obesity 2 (7.1%) 1 (4%) .21
COPD 5 (17.8%) 3 (12%) .32
Neoplasm 4 (14.3%) 0 (0%) .05
Current or previous smoke 18 (64.3%) 12 (48%) .22
Anatomical data
(Mean ± SD), mm
Proximal aortic neck
diameter
25 ± 1.8 24 ± 1.2 .15
Proximal aortic neck lenght 20 ± 5 21 ± 1.2 .21
Distal aortic neck diameter 22 ± 0.2 18 ± 0.7 .34
Distal aortic neck lenght 24 ± 1.2 10 ± 2 .07
Angulation of proximal aortic
neck (degrees)
30° ± 7.5° 35° ± 12° .09
Sac diameter (range) 5.2 (5.0-8.4) 5.1 (4.6-6.2) .12
Aortic length 84 (60–120) 89 (75–114) .08
* IMH = Intra Mural Hematoma.
PAU = Parietal Aortic Ulcer.
PSA = Pseudoaneurysm.
TIA = Transient Ischaemic Attack.
COPD = Chronic Obstructive Pulmonary Disease.
Table 2 Intraprocedural and in-hospital data (Mean ± SD)
Single tube
(n = 28)
Trombone technique
(n = 25)
P value
Time of
operation (min)
31.1 ± 3 42 ± 4 .06
Amount of
contrast (cc)
26.5 ± 2.5 38.2 ± 3.4 .05
Fluoroscopy
time (min)
9.2 ± 1.4 15.2 ± 2 .05
Blood loss (cc) 120 ± 13 152 ± 11 .06
Adjunctive
procedure
2/28 (7.1%) 2/25 (8%) .12
Length of stay
(days)
3.2 ± 0.8 3.1 ± 0.5 .25
Table 3 Summary of early and late events during
follow-up for both groups
Single tube Trombone
technique
P
30-days
Endoleak I 1/28 (3.6%) 0/25 (0%) .09
Post-implantation
syndrome
4/28 (14.3%) 2/25 (8%) .22
Reintervention 1/28 (3.6%) 0/25 (0%) .09
Long term
Endoleak I 5/28 (17.8%) 0/24 (0%) .02
Endoleak II 1/28 (3.6%) 0/24 (0%) .08
Graft infection 1/28 (3.6%) 0/24 (0%) .08
Stent fracture 0/28 (0%) 1/24 (4%) .07
Reintervention 5/28 (17.8%) 1/24 (4%) .03
Rupture 1/28 (3.6%) 0/24 (0%) .08
Death 5/28 (17.8%) 0/24 (0%) .02
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postoperative month respectively. The remaining patient
died for aortic rupture after 28 months, but he had re-
fused any visit after operation and we had follow-up data
only through telephonic interview.
In group B no patients died and no aortic rupture oc-
curred. Follow-up data were available for 24 out of 25
patients of this group, as one was lost.
Endoleaks occurred more frequently in patients who re-
ceived a single straight tube (Table 3). In particular, we ob-
served 4 type Ib endoleaks, 1 type Ia endoleak and 1 type
II endoleak from a lumbar artery. Endoleaks were diag-
nosed respectively after 13, 25, 27, 60, 52 and 22 months
from the operation. An adding cuff was placed in all casesof type I endoleaks, but complete exclusion of the
aneurysmatic sac was achieved in 3 cases only. In the case
of type Ia endoleak, the single tube had been placed to
correct a proximal anastomotic pseudoaneurysm after
OSR. Once the endoleak had been diagnosed, a second
endovascular attempt was performed to exclude the leak-
age but symptoms of a serious graft infection became evi-
dent. Thus the patient underwent surgical explantation of
all grafts after axillo-bifemoral bypass at 52 months.
In the remaining case, late conversion to open surgery
was necessary for persistency of flow throughout the sac
in the 60th postoperative month. The patient with type II
endoleak is still under semestral surveillance, as the
aneurysmatic sac has not showed any sign of growth yet.
Reintervention was more frequent for patients of
group A, being type I endoleak the main cause (Table 3).
There were no reinterventions for graft thrombosis. A
stent fracture was observed in a patient who received
EVAR by “trombone technique” 3 months later. The
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tion. Reintervention was then necessary and a third stent
was successfully placed to cover the lesion.
Discussion
Many studies in the literature [5-7] demonstrated that
endovascular treatment of abdominal aortic aneurysms
(EVAR) was associated with lower postoperative mortal-
ity and morbidity rates compared to open surgery repair
(OSR), but this advantage seemed to decrease at long
term because of higher reintervention rates in EVAR
group.
The overview of the patients who underwent EVAR, in
fact, progressively worsened with the progression of
follow-up: EVAR-1 [5] showed that after 4 years compli-
cation rate was five times higher than after OSR, being
type I and type II endoleak, migration of the graft and
graft thrombosis the main causes of complications.
These factors lead mostly to reinterventions, which were
three times more frequent. The same findings were
reported by the DREAM [6] group during the first nine
months of follow-up.
Wilt and Coll. too [7], in a large meta-analysis performed
in 2006 showed that EVAR did not improve long-term sur-
vival or health status over OSR, though peri-operative out-
comes were improved. Moreover EVAR was associated
with more complications, need for reintervention, moni-
toring and costs compared to OSR or no intervention. Re-
cent SVS Guidelines [8] substantially confirmed these
findings.
Thus reintervention still remains the Achilles heel of
EVAR, and this factor must be strongly considered as it
represents adding cost for society, in a period in which
the availability of increasingly expensive devices has to
face the need for containment of the outgoings.
While acknowledging the inferiority of EVAR com-
pared to OSR, Wilt and Coll. [7] admitted however that
most of analyzed studies were performed using dating
models of endoprosthesis and hoped future research
about devices and techniques to reduce postoperative
complications.
SVS guidelines too [8] advocated the need for further
improvements in EVAR devices and related techniques
to reduce long-term complications and overall cost.
The use of tubular devices, although previously con-
signed to history by the wide criticism about poor durabil-
ity over time, has been recently recalled. Aorto-aortic
tubes have a series of advantages over bifurcated and con-
ical grafts. The implantation procedure usually takes less
time and radiations and the overall cost is substantially re-
duced [9]. Tubular endografts are also less likely to oc-
clude as they have no kinking or twisting, if compared to
bifurcated and aorto-monoiliac devices [10]. In our series,
in fact, we did not observe any graft thrombosis. This factmay lead to the reduction of reintervention due to graft
occlusion, but concern remains about exclusion of the
aneurysmatic sac over time. The single tube in fact may
lack of both columnar support and distal sealing, causing
mainly type Ib endoleak, as reported in our series. More-
over, type Ib endoleak can be due to aneurysmatic degen-
eration of the remaining portion of the pre-carrefour
abdominal aorta. Implantation of a second stent-graft
within the distal end of the first tube then has been pro-
posed [11]. This modified technique (“trombone tech-
nique”) allowed the two stent-grafts to be implanted in the
correct position relative both to the proximal and to the
distal implantation site, thus minimizing the risk of type I
endoleak.
In 2007 Ruppert et al. [4] reported their experience
about the use of the trombone technique as a planned
procedure for deploying tubular aorto-aortic stent-grafts.
He described very promising early and midterm results,
which compared favorably to those reported for bifur-
cated devices and open repair.
In 2008 Saratzis and Coll. [9] too evaluated this tech-
nique comparing outcomes of 45 patients electively
treated for AAA using the trombone technique to 8 pa-
tients who received single tube grafts. They observed
that the overall device-related complication rate was sig-
nificantly lower for patients treated with the trombone
technique (11% versus 75%, p = .001).
The results observed in our series are consistent with
those reported by these authors.
In our series, in fact, we observed that all endoleaks
and reinterventions at long term occurred in patients
who were treated using a single straight endograft. On
the other side, blood loss, fluoroscopy time and length
of procedure were slightly lower if compared to those of
“trombone technique”.
Making a comparison is difficult, however, given the
small number of patients in our series, with a disease
which is strictly limited to the infrarenal aortic segment.
These factors are the major limitations of our study and
do not allow to generalize the results obtained.
Conclusions
In our experience the endovascular repair of AAA using
straight aortic endografts was safe and effective. Rein-
tervention and endoleaks were slightly more frequent in
patients who had received a single endograft compared to
patients who were treated using the “trombone tech-
nique”. On the other side, blood loss, intraoperative time
of fluoroscopy and intervention time were slightly lower if
a single tube had been used.
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